MA27108A1 - Derives d'aminocycloalcanecarboxamide de n-biphenylmethyle avec un substituant sur le methyle utiles comme antagonistes de la bradykinine - Google Patents
Derives d'aminocycloalcanecarboxamide de n-biphenylmethyle avec un substituant sur le methyle utiles comme antagonistes de la bradykinineInfo
- Publication number
- MA27108A1 MA27108A1 MA27820A MA27820A MA27108A1 MA 27108 A1 MA27108 A1 MA 27108A1 MA 27820 A MA27820 A MA 27820A MA 27820 A MA27820 A MA 27820A MA 27108 A1 MA27108 A1 MA 27108A1
- Authority
- MA
- Morocco
- Prior art keywords
- aminocycloalcanecarboxamide
- biphenylmethyl
- derivatives
- bradykinin antagonists
- methyl substitute
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35506202P | 2002-02-08 | 2002-02-08 | |
US41017202P | 2002-09-12 | 2002-09-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA27108A1 true MA27108A1 (fr) | 2004-12-20 |
Family
ID=27737481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA27820A MA27108A1 (fr) | 2002-02-08 | 2004-08-10 | Derives d'aminocycloalcanecarboxamide de n-biphenylmethyle avec un substituant sur le methyle utiles comme antagonistes de la bradykinine |
Country Status (27)
Country | Link |
---|---|
US (2) | US6919343B2 (fr) |
EP (1) | EP1501787B1 (fr) |
JP (1) | JP4098249B2 (fr) |
KR (1) | KR20040083440A (fr) |
CN (1) | CN1328247C (fr) |
AR (1) | AR038377A1 (fr) |
AT (1) | ATE309202T1 (fr) |
AU (1) | AU2003216169B2 (fr) |
BR (1) | BR0307508A (fr) |
CA (1) | CA2474373C (fr) |
DE (1) | DE60302240T2 (fr) |
DK (1) | DK1501787T3 (fr) |
EA (1) | EA007297B1 (fr) |
EC (1) | ECSP045217A (fr) |
ES (1) | ES2250899T3 (fr) |
HR (1) | HRP20040677A2 (fr) |
IS (1) | IS7372A (fr) |
JO (1) | JO2356B1 (fr) |
MA (1) | MA27108A1 (fr) |
MX (1) | MXPA04007660A (fr) |
NO (1) | NO20043739L (fr) |
NZ (1) | NZ534062A (fr) |
PE (1) | PE20030986A1 (fr) |
PL (1) | PL371664A1 (fr) |
RS (1) | RS65404A (fr) |
TW (1) | TWI259079B (fr) |
WO (1) | WO2003066577A1 (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003057671A1 (fr) * | 2001-12-28 | 2003-07-17 | Takeda Chemical Industries, Ltd. | Compose biaryle et son utilisation |
ATE316954T1 (de) * | 2002-02-08 | 2006-02-15 | Merck & Co Inc | N-biphenylmethylaminocycloalkancarboxamid- derivative |
RU2005108667A (ru) * | 2002-08-29 | 2005-08-27 | Мерк энд Ко., Инк. (US) | Производные n-биарилметиламиноциклоалканкарбоксамида |
CA2509881A1 (fr) * | 2002-12-19 | 2004-07-08 | Elan Pharmaceuticals, Inc. | Antagonistes de la bradykinine a substitution n-phenylsulfonamide |
JP2007501790A (ja) * | 2003-08-07 | 2007-02-01 | メルク エンド カムパニー インコーポレーテッド | スルホニル置換n−(ビアリールメチル)アミノシクロプロパンカルボキサミド |
CA2550372C (fr) * | 2003-12-22 | 2009-09-29 | Merck & Co., Inc. | Alpha-hydroxy amides utilises comme antagonistes ou agonistes inverses de la bradykinine |
CA2557858A1 (fr) * | 2004-03-02 | 2005-09-15 | Merck & Co., Inc. | Derives d'amino cyclopropane carboxamide utilises comme antagonistes de la bradykinine |
US20050245543A1 (en) * | 2004-04-30 | 2005-11-03 | Pfizer Inc | Histamine-3 receptor antagonists |
MX2007001348A (es) * | 2004-08-02 | 2008-03-11 | Bebaas Inc | Composiciones de vitamina b12. |
DE102004060542A1 (de) * | 2004-12-16 | 2006-07-06 | Sanofi-Aventis Deutschland Gmbh | Hydroxybiphenyl-Carbonsäuren und Derivate, Verfahren zu deren Herstellung und deren Verwendung |
SI1830869T1 (sl) * | 2004-12-24 | 2013-12-31 | Spinifex Pharmaceuticals Pty Ltd | Postopek zdravljenja ali profilakse |
US20070178141A1 (en) * | 2005-09-07 | 2007-08-02 | Bebaas, Inc. | Vitamin B12 compositions |
US20130131007A1 (en) | 2005-09-07 | 2013-05-23 | Bebaas, Inc. | Vitamin b12 compositions |
CA2866540A1 (fr) * | 2006-03-20 | 2007-09-27 | Spinifex Pharmaceuticals Pty Ltd. | Methode de traitement prophylactique ou therapeutique |
US8945505B2 (en) * | 2007-02-02 | 2015-02-03 | Panaphix, Inc. | Use of arsenic compounds for treatment of pain and inflammation |
EP2155643B1 (fr) | 2007-06-08 | 2016-08-10 | MannKind Corporation | Inhibiteurs d'ire-1a |
CL2008002545A1 (es) * | 2007-08-29 | 2009-10-23 | Boehringer Ingelheim Int | Compuestos derivados de fenoxi-bencil-carbamoilo; composicion farmaceutica; procedimiento para preparar la composicion farmaceutica; y su uso en el tratamiento del dolor. |
WO2009132453A1 (fr) * | 2008-04-28 | 2009-11-05 | Neuromed Pharmaceuticals Ltd. | Dérivés de cyclylamine utilisés comme agents bloquant le canal calcique |
GEP20135933B (en) * | 2009-02-26 | 2013-10-10 | Boehringer Ingelheim Int | Compounds as bradykinin b1 antagonists |
WO2010097373A1 (fr) * | 2009-02-26 | 2010-09-02 | Boehringer Ingelheim International Gmbh | Composés servant d'antagonistes de bradykinine b1 |
WO2010097374A1 (fr) * | 2009-02-26 | 2010-09-02 | Boehringer Ingelheim International Gmbh | Composés servant d'antagonistes de bradykinine b1 |
WO2011133571A2 (fr) | 2010-04-19 | 2011-10-27 | Board Of Trustees Of Michigan State University | Biomasse lignocellulosique digestible, produits d'extraction du bois et procédés de production associés |
US10457810B2 (en) | 2009-08-24 | 2019-10-29 | Board Of Trustees Of Michigan State University | Densified biomass products containing pretreated biomass fibers |
PT2539323E (pt) | 2010-02-23 | 2015-02-16 | Boehringer Ingelheim Int | Compostos como antagonistas da bradicinina b1 |
US8937073B2 (en) * | 2010-08-20 | 2015-01-20 | Boehringer Ingelheim International Gmbh | Disubstituted tetrahydrofuranyl compounds and their use as B1-receptor antagonists |
HUP1000598A2 (en) * | 2010-11-05 | 2012-09-28 | Richter Gedeon Nyrt | Indole derivatives |
US8912221B2 (en) * | 2010-12-27 | 2014-12-16 | Hoffmann-La Roche Inc. | Biaryl amide derivatives |
US8592426B2 (en) * | 2011-01-24 | 2013-11-26 | Hoffmann—La Roche Inc. | Aryl-benzocycloalkyl amide derivatives |
MX2020004557A (es) | 2017-11-02 | 2020-10-05 | Calico Life Sciences Llc | Moduladores de la vía de estrés integrada. |
TWI771621B (zh) | 2018-10-11 | 2022-07-21 | 美商嘉來克生命科學有限責任公司 | 整合應激路徑之前藥調節劑 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270317A (en) * | 1990-03-20 | 1993-12-14 | Elf Sanofi | N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
IL99372A0 (en) | 1990-09-10 | 1992-08-18 | Ciba Geigy Ag | Azacyclic compounds |
US5208236A (en) * | 1992-09-23 | 1993-05-04 | Schering Corporation | N-(acylaminomethyl)glutaryl amino acids and use |
DE69424846T2 (de) | 1993-11-16 | 2000-11-16 | Novartis Ag | Zyklische Aminosäure-Derivate mit ACE und NEP inhibierender Aktivität |
WO1997011717A1 (fr) | 1995-09-27 | 1997-04-03 | Novartis Ag | Traitement de l'insuffisance renale chronique et progressive |
FR2743562B1 (fr) * | 1996-01-11 | 1998-04-03 | Sanofi Sa | Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant |
US6433185B1 (en) * | 1996-01-11 | 2002-08-13 | Sanofi-Synthelabo | N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
BR9909805A (pt) | 1998-04-23 | 2000-12-26 | Novartis Ag | Certos inibidores de tiol de enzima de conversão de endotelina |
ES2237917T3 (es) | 1998-04-23 | 2005-08-01 | Novartis Ag | Ciertos inhibidores tiolicos substituidos con heteroarilo de enzima conversora de endotelina. |
US20020052370A1 (en) | 2000-07-06 | 2002-05-02 | Barber Christopher Gordon | Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
DE10036121A1 (de) | 2000-07-25 | 2002-02-07 | Merck Patent Gmbh | N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate |
ATE316954T1 (de) | 2002-02-08 | 2006-02-15 | Merck & Co Inc | N-biphenylmethylaminocycloalkancarboxamid- derivative |
-
2003
- 2003-01-30 TW TW092102107A patent/TWI259079B/zh not_active IP Right Cessation
- 2003-01-30 US US10/354,674 patent/US6919343B2/en not_active Expired - Lifetime
- 2003-01-30 AR ARP030100276A patent/AR038377A1/es not_active Application Discontinuation
- 2003-02-04 PE PE2003000132A patent/PE20030986A1/es not_active Application Discontinuation
- 2003-02-04 CN CNB03803560XA patent/CN1328247C/zh not_active Expired - Fee Related
- 2003-02-04 AU AU2003216169A patent/AU2003216169B2/en not_active Ceased
- 2003-02-04 BR BR0307508-7A patent/BR0307508A/pt not_active IP Right Cessation
- 2003-02-04 NZ NZ534062A patent/NZ534062A/en unknown
- 2003-02-04 AT AT03737624T patent/ATE309202T1/de not_active IP Right Cessation
- 2003-02-04 DE DE60302240T patent/DE60302240T2/de not_active Expired - Lifetime
- 2003-02-04 RS YUP-654/04A patent/RS65404A/sr unknown
- 2003-02-04 JP JP2003565952A patent/JP4098249B2/ja not_active Expired - Fee Related
- 2003-02-04 KR KR10-2004-7012238A patent/KR20040083440A/ko not_active Application Discontinuation
- 2003-02-04 EA EA200401054A patent/EA007297B1/ru not_active IP Right Cessation
- 2003-02-04 PL PL03371664A patent/PL371664A1/xx unknown
- 2003-02-04 ES ES03737624T patent/ES2250899T3/es not_active Expired - Lifetime
- 2003-02-04 DK DK03737624T patent/DK1501787T3/da active
- 2003-02-04 CA CA002474373A patent/CA2474373C/fr not_active Expired - Fee Related
- 2003-02-04 WO PCT/US2003/003338 patent/WO2003066577A1/fr active IP Right Grant
- 2003-02-04 US US10/503,501 patent/US20050084463A1/en not_active Abandoned
- 2003-02-04 EP EP03737624A patent/EP1501787B1/fr not_active Expired - Lifetime
- 2003-02-04 MX MXPA04007660A patent/MXPA04007660A/es unknown
- 2003-02-06 JO JO200315A patent/JO2356B1/en active
-
2004
- 2004-07-23 HR HR20040677A patent/HRP20040677A2/hr not_active Application Discontinuation
- 2004-07-26 IS IS7372A patent/IS7372A/is unknown
- 2004-08-02 EC EC2004005217A patent/ECSP045217A/es unknown
- 2004-08-10 MA MA27820A patent/MA27108A1/fr unknown
- 2004-09-07 NO NO20043739A patent/NO20043739L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27108A1 (fr) | Derives d'aminocycloalcanecarboxamide de n-biphenylmethyle avec un substituant sur le methyle utiles comme antagonistes de la bradykinine | |
FR18C1024I1 (fr) | Derives d'heterocyclocarboxamide | |
IL164135A0 (en) | 4-Anilino quinazoline derivatives as antirpoliferative agents | |
MA26816A1 (fr) | Derives d'amino-triazolopyridine | |
IS7314A (is) | 5,6-díarýl-pýrasín-2-amíðafleiður sem cb1 mótlyf | |
IS2467B (is) | 3-azabísýkló[3.1.0]hexanafleiður sem ópíumefna viðtakabindlar | |
DK1416935T3 (da) | 4-Amino-6-phenyl-pyrrolo[2,3-d]pyrimidinderivater | |
FR2844203B1 (fr) | Parfumeur d'ambiance | |
HK1058361A1 (en) | Urea derivatives as integrin alpha 4 antagonists | |
DE50302202D1 (de) | Neue 2,5-disubstituierte pyrimidinderivate | |
ITMI20001830A0 (it) | Struttura artificiale d'arrampicata. | |
MXPA03006991A (es) | Derivados de piperidina como antagonistas de neurocinina 1. | |
IL148623A0 (en) | Thienoisoxazolyl-and thienylpyrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists | |
ZA200610455B (en) | 4-Anilino Quinazoline derivatives as antiproliferative agents | |
FR2791043B3 (fr) | Pulverisateur d'assaisonnement | |
ATE277912T1 (de) | Pyrimidine-2,4,6-trione als matrixmetalloproteinase-hemmer | |
MA26844A1 (fr) | Nouveaux derives de la thiazolidinedione comme agents antidiabetiques | |
GB0304379D0 (en) | Roller-typed paintbrush's structural improvement | |
DE60315367D1 (de) | Darrieus Windturbine | |
MA27240A1 (fr) | Derives d'imidazoquinoleine | |
ES1054475Y (es) | "cubo de basura domestico" | |
FR2832922B1 (fr) | Prothese d'epaule | |
FR2846676B1 (fr) | Fondations d'un pylone ou similaire | |
NO20011309D0 (no) | Benzotieno [3,2-c]pyridiner som<alfa>2-antagonister | |
TWI320409B (en) | Urea derivatives as integrin 4 antagonists |